Prudential Financial’s Albireo Pharma Inc ALBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,700
Closed -$498K 2737
2022
Q3
$498K Sell
25,700
-41,800
-62% -$864K ﹤0.01% 2070
2022
Q2
$1.34M Sell
67,500
-33,300
-33% -$878K ﹤0.01% 1629
2022
Q1
$3.01M Buy
100,800
+84,900
+534% +$2.49M ﹤0.01% 1269
2021
Q4
$370K Buy
+15,900
New +$423K ﹤0.01% 2322
2020
Q3
Sell
-27,446
Closed -$727K 2498
2020
Q2
$727K Sell
27,446
-2,941
-10% -$69.4K ﹤0.01% 1780
2020
Q1
$498K Sell
30,387
-2,788
-8% -$61.3K ﹤0.01% 1914
2019
Q4
$843K Buy
33,175
+105
+0.3% +$2.1K ﹤0.01% 1920
2019
Q3
$661K Buy
33,070
+3,453
+12% +$89.4K ﹤0.01% 1972
2019
Q2
$954K Buy
29,617
+30
+0.1% +$1K ﹤0.01% 1891
2019
Q1
$953K Buy
29,587
+3,031
+11% +$81.6K ﹤0.01% 1895
2018
Q4
$652K Buy
26,556
+1,404
+6% +$37.1K ﹤0.01% 1939
2018
Q3
$829K Buy
25,152
+2,075
+9% +$67.9K ﹤0.01% 1922
2018
Q2
$820K Buy
+23,077
New +$748K ﹤0.01% 1947

Other funds holding ALBO

Prudential Financial's ALBO Position: Q4 2022 in Review

Prudential Financial sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 25,700 shares — an estimated $498K sold.

Prudential Financial first reported a position in ALBO in Q2 2018 and held it in 13 quarters. The position peaked at $3.01M in Q1 2022. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • Prudential Financial reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • Prudential Financial sold 25,700 Albireo Pharma Inc shares in Q4 2022, an estimated $498K.
  • Prudential Financial first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 13 quarters.
  • Prudential Financial's Albireo Pharma Inc position peaked at $3.01M in Q1 2022.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on Prudential Financial's 13F filing for Q4 2022, filed 14 Feb 2023.